Printer Friendly

APPLIED BIOSCIENCE INTERNATIONAL APPOINTS TIMONEY SENIOR VICE PRESIDENT, AMUNDSEN CHIEF FINANCIAL OFFICER

 APPLIED BIOSCIENCE INTERNATIONAL APPOINTS
 TIMONEY SENIOR VICE PRESIDENT, AMUNDSEN CHIEF FINANCIAL OFFICER
 EAST MILLSTONE, N.J., July 7 /PRNewswire/ -- Kenneth H. Harper, chairman and CEO of Applied Bioscience International Inc. (NASDAQ: APBI) announced today that John H. Timoney, has been appointed senior vice president. Timoney, who has been with the company since its inception, has been given special responsibility for investor relations and involvement in strategic planning,
mergers and acquisitions. At the same time, the board confirmed the appointment of Robert F. Amundsen as chief financial officer of Applied Bioscience International Inc. Amundsen was previously chief financial officer of Pharmaco, now part of APBI since the two companies merged earlier this year.
 APBI provides a broad range of interrelated services, which includes biological safety testing, clinical research and development, agrochemical research and development and the management and assessment of environmental risk. The company provides these services under contract to clients in the pharmaceutical, general chemical, agrochemical, food and other industries throughout the world.
 -0- 7/7/92
 /CONTACT: John H. Timoney, senior vice president of Applied Bioscience International, 908-873-2550, or John McNamara of John McNamara Advertising, 212-509-7779, for Applied Bioscience International/
 (APBI) CO: Applied Bioscience International Inc. ST: New Jersey IN: MTC SU: PER


SH-TS -- NY025 -- 6932 07/07/92 10:46 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 7, 1992
Words:213
Previous Article:CELOX CORPORATION ANNOUNCES APPOINTMENT
Next Article:BARCELONA '92 OLYMPIC INFORMATION SYSTEM BASED ON IBM'S OS/2
Topics:


Related Articles
APPLIED BIOSCIENCE INTERNATIONAL ANNOUNCES TWO-FOR-ONE STOCK SPLIT
APPLIED BIOSCIENCE INTERNATIONAL REPORTS SECOND QUARTER AND SIX MONTH FINANCIAL RESULTS
APPLIED BIOSCIENCE INTERNATIONAL INC. ELECTS SWEP T. DAVIS TO BOARD OF DIRECTORS AND APPOINTS HIM PRESIDENT, ENVIRONMENTAL SCIENCES GROUP
APPLIED BIOSCIENCE INTERNATIONAL INC. ANNOUNCES STOCK REPURCHASE PROGRAM OF UP TO 1 MILLION SHARES OF COMMON STOCK
APPLIED BIOSCIENCE INTERNATIONAL INC. APPOINTS BRACKEN VICE PRESIDENT, MARKETING AND BUSINESS DEVELOPMENT, ENVIRONMENTAL SCIENCES GROUP
APPLIED BIOSCIENCE INTERNATIONAL INC. REPORTS FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
STEVEN A. FLECKMAN APPOINTED TO BOARD OF APPLIED BIOSCIENCE INTERNATIONAL, INC.
APPLIED BIOSCIENCE INTERNATIONAL INC. ANNOUNCES INCREASE IN SHARE REPURCHASE PROGRAM FROM ONE MILLION SHARES TO TWO MILLION SHARES
Triangle Pharmaceuticals, Inc. Appoints Robert Amundsen, Jr. as Chief Financial Officer and Andrew Finkle as General Counsel.
Executive changes. (Random Samples).

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters